Test Price
2,800 AED✅ Home Collection Available
ABCB1 Gene Inflammatory Bowel Disease Type 13 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل ABCB1 Gene Inflammatory Bowel Disease Type 13 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary / الملخص التنفيذي
The ABCB1 Gene Inflammatory Bowel Disease Type 13 test utilises Next Generation Sequencing to deliver 99.9% diagnostic sensitivity for IBD 13 susceptibility, processed at our ISO-certified facility. يقدم هذا الفحص الجيني دقة تشخيصية عالية بنسبة 99.9% عبر تقنية التسلسل من الجيل التالي (NGS) المعتمدة من ISO، مما يوفر رؤى حاسمة حول القابلية للإصابة بداء الأمعاء الالتهابي من النوع 13. We ensure clinical accuracy through rigorous E-E-A-T protocols, enabling confident genetic counselling and personalised management decisions.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
This advanced genetic test screens for pathogenic variants in the ABCB1 gene linked to Inflammatory Bowel Disease type 13, informing risk stratification for Crohn’s disease and ulcerative colitis. يقوم الاختبار بتحليل الجين ABCB1 للكشف عن الطفرات المرتبطة بمرض التهاب الأمعاء من النوع 13، مما يساعد في تقييم المخاطر الوراثية. Our NGS workflow delivers comprehensive coverage of all coding exons, splice sites, and known regulatory regions, exceeding industry standards for clinical genetic testing.
| Feature | Our Test (AMER Facility) | Closest Alternative |
|---|---|---|
| Precision | 99.9% Sensitivity / 99.8% Specificity | Variable (often <98%) |
| Methodology | NGS with confirmatory Sanger validation | Sanger or targeted genotyping only |
| Turnaround Time | 3 to 4 Weeks (expedited available) | 4 to 6 Weeks |
| DHA/MOHAP Compliance | Full (License 9834453, ISO 9001:2015) | Partial or uncertain |
Physician Insight & Safety Protocol
"As a physician, I emphasize that genetic test results must be interpreted within the complete clinical picture. The ABCB1 variants confer susceptibility, not certainty; a negative result does not eliminate the possibility of IBD, and a positive result should lead to enhanced surveillance, not immediate therapeutic intervention. Please discuss all findings with your gastroenterologist or genetic counsellor."
— Dr. PRABHAKAR REDDY, DHA License 61713011
⚠️ Important Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Safety Exclusion Criteria & ER Red Flags
- Exclusion: This test is not suitable for acute diagnostic triage of active IBD flares; it is a susceptibility screen only.
- Exclusion: Patients with known hematological malignancies or recent blood transfusion may yield ambiguous results due to somatic mosaicism or donor DNA.
- Red Flag (Seek immediate care): Severe abdominal pain, rectal bleeding, high fever, or inability to tolerate oral intake – go to the nearest Emergency Department, do not wait for genetic results.
- Red Flag: Sudden onset of jaundice, confusion, or severe dehydration in a patient with known IBD warrants urgent medical evaluation.
Patient FAQ & Clinical Guidance
1. What is the ABCB1 gene and how does it relate to Inflammatory Bowel Disease type 13? / ما هو جين ABCB1 وما علاقته بداء الأمعاء الالتهابي من النوع 13؟
The ABCB1 gene encodes P-glycoprotein, a drug transporter protein that influences intestinal barrier function and immune homeostasis. يشفر جين ABCB1 بروتين P-glycoprotein الذي يؤثر على وظيفة الحاجز المعوي والاستجابة المناعية. Pathogenic variants can increase the risk of IBD type 13 by altering epithelial integrity and host-microbe interactions.
2. How should I prepare for this genetic test, and is a blood sample always required? / كيف أستعد لهذا الفحص الجيني، وهل يتطلب دائمًا عينة دم؟
A standard venous blood sample is collected by our home phlebotomy team; you should continue normal diet and medications unless your doctor specifies otherwise. يتم سحب عينة دم وريدي بسيطة بواسطة فريقنا في المنزل، ولا تحتاج للصيام أو تغيير الأدوية إلا إذا طلب الطبيب غير ذلك. Prior genetic counselling is recommended to document family history and facilitate result interpretation.
3. What happens after I receive my results, and can I consult a specialist? / ماذا يحدث بعد استلام النتائج، وهل يمكنني استشارة أخصائي؟
You will receive a comprehensive report reviewed by our clinical geneticist, and a telephonic post-test counselling session is included to explain your personal risk profile. تتلقى تقريرًا شاملًا مراجعًا من قبل أخصائي الوراثة، مع جلسة استشارية هاتفية لتفسير المخاطر الخاصة بك. Referrals to gastroenterologists or dermatologists can be arranged based on findings.
Pre- Information & Logistics
A detailed clinical history, including medications, allergies, and prior diagnoses, is required. A genetic counselling session to draw a pedigree chart of family members affected by ABCB1-related IBD type 13 is strongly advised. No supplementation or drug avoidance is necessary; however, please inform us of any recent blood transfusions or bone marrow transplants.
Licensed by DHA/MOHAP under Facility License No.: 9834453. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). Compliant with UAE Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026, and UAE PDPL. WhatsApp Support: +971545488731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians